• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鲁比前列酮可减少小鼠结肠内黏液层厚度并改变肠道微生物群。

Lubiprostone decreases mouse colonic inner mucus layer thickness and alters intestinal microbiota.

机构信息

Division of Biological Sciences, Department of Medicine, The University of Chicago, 900 E. 57th St., Chicago, IL 60637, USA.

出版信息

Dig Dis Sci. 2013 Mar;58(3):668-77. doi: 10.1007/s10620-012-2509-5. Epub 2013 Jan 18.

DOI:10.1007/s10620-012-2509-5
PMID:23329012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3618493/
Abstract

BACKGROUND

Lubiprostone has been used to treat constipation through its effects to stimulate Cl(-) secretion, resulting in water and electrolyte secretion.

AIM

Potential associated changes in intestinal mucus and the colonizing bacteria (microbiome) have not been studied. As mucus obstructions may play a role in cystic fibrosis, the hypothesis that lubiprostone alters intestinal mucus and the microbiome was investigated.

METHODS

Ion transport studies were performed ex vivo. For mucus and microbiome studies, mice were gavaged daily with lubiprostone or vehicle. Mucin from intestinal sections was analyzed in Carnoy's fixed tissues stained with Alcian blue. Microbiome composition was analyzed by 16S rRNA gene-based sequencing.

RESULTS

Lubiprostone stimulated short circuit current in all mouse intestinal segments after both serosal and mucosal additions, albeit at lower concentrations in the latter. Current was Cl-dependent and blocked by mucosal diphenylcarboxylic acid, serosal bumetanide, and serosal Ba(++). The CFTR inhibitor CFTRinh172 had a marginal effect. Mucus near epithelial cells (inner layer mucus) was not present in the small intestine of any mice. Proximal colon inner mucus layer was thicker in ∆F/∆F compared with +/∆F and +/+ mice. Lubiprostone decreased inner mucus layer thickness in both proximal and distal colon of all mice. Furthermore, lubiprostone altered the intestinal microbiome by increasing abundance of Lactobacillus and Alistipes.

CONCLUSIONS

Lubiprostone activates non-CFTR Cl(-) secretion and alters the colonic inner mucus layer, which is associated with changes in the composition of the enteric microbiome.

摘要

背景

鲁比前列酮通过刺激 Cl(-)分泌来治疗便秘,从而导致水和电解质分泌。

目的

尚未研究肠道黏液和定植细菌(微生物组)的潜在相关变化。由于黏液阻塞可能在囊性纤维化中起作用,因此研究了鲁比前列酮改变肠道黏液和微生物组的假设。

方法

在离体条件下进行离子转运研究。对于黏液和微生物组研究,每天用鲁比前列酮或载体灌胃小鼠。用 Alcian 蓝染色的 Carnoy 固定组织分析肠段中的粘蛋白。通过基于 16S rRNA 基因的测序分析微生物组组成。

结果

鲁比前列酮在所有小鼠肠道段的浆膜和黏膜后均刺激短路电流,尽管后者的浓度较低。电流是 Cl(-)依赖性的,并被黏膜二苯甲酮酸、浆膜布美他尼和浆膜 Ba(++) 阻断。CFTR 抑制剂 CFTRinh172 仅有轻微作用。没有任何小鼠的小肠上皮细胞附近存在黏液(内层黏液)。与+/∆F 和 +/+ 小鼠相比,∆F/∆F 小鼠的近端结肠内层黏液层更厚。鲁比前列酮减少了所有小鼠近端和远端结肠的内层黏液层厚度。此外,鲁比前列酮通过增加乳杆菌和 Alistipes 的丰度改变了肠道微生物组。

结论

鲁比前列酮激活非 CFTR Cl(-)分泌并改变结肠内层黏液层,这与肠内微生物组组成的变化有关。

相似文献

1
Lubiprostone decreases mouse colonic inner mucus layer thickness and alters intestinal microbiota.鲁比前列酮可减少小鼠结肠内黏液层厚度并改变肠道微生物群。
Dig Dis Sci. 2013 Mar;58(3):668-77. doi: 10.1007/s10620-012-2509-5. Epub 2013 Jan 18.
2
Lubiprostone ameliorates the cystic fibrosis mouse intestinal phenotype.利那洛肽改善囊性纤维化小鼠的肠道表型。
BMC Gastroenterol. 2010 Sep 15;10:107. doi: 10.1186/1471-230X-10-107.
3
Activation of intestinal Cl- secretion by lubiprostone requires the cystic fibrosis transmembrane conductance regulator.鲁比前列酮激活肠道氯离子分泌需要囊性纤维化跨膜传导调节因子。
Gastroenterology. 2009 Sep;137(3):976-85. doi: 10.1053/j.gastro.2009.05.037. Epub 2009 May 18.
4
Lubiprostone targets prostanoid signaling and promotes ion transporter trafficking, mucus exocytosis, and contractility.鲁比前列酮靶向前列腺素信号通路并促进离子转运体转运、黏液分泌和收缩性。
Dig Dis Sci. 2012 Nov;57(11):2826-45. doi: 10.1007/s10620-012-2352-8. Epub 2012 Aug 25.
5
Lubiprostone activates Cl- secretion via cAMP signaling and increases membrane CFTR in the human colon carcinoma cell line, T84.鲁比前列酮通过 cAMP 信号激活 Cl-分泌,并增加人结肠癌细胞系 T84 中的膜 CFTR。
Dig Dis Sci. 2011 Feb;56(2):339-51. doi: 10.1007/s10620-010-1495-8. Epub 2010 Dec 8.
6
Recovery of mucosal barrier function in ischemic porcine ileum and colon is stimulated by a novel agonist of the ClC-2 chloride channel, lubiprostone.新型 ClC-2 氯通道激动剂鲁比前列酮可促进缺血猪回肠和结肠黏膜屏障功能的恢复。
Am J Physiol Gastrointest Liver Physiol. 2007 Feb;292(2):G647-56. doi: 10.1152/ajpgi.00183.2006. Epub 2006 Oct 19.
7
Lubiprostone stimulates small intestinal mucin release.鲁比前列酮可刺激小肠黏液释放。
BMC Gastroenterol. 2012 Nov 6;12:156. doi: 10.1186/1471-230X-12-156.
8
Lubiprostone stimulates duodenal bicarbonate secretion in rats.鲁比前列酮刺激大鼠十二指肠碳酸氢盐分泌。
Dig Dis Sci. 2009 Oct;54(10):2063-9. doi: 10.1007/s10620-009-0907-0. Epub 2009 Aug 6.
9
Lubiprostone prevents nonsteroidal anti-inflammatory drug-induced small intestinal damage by suppressing the expression of inflammatory mediators via EP4 receptors.鲁比前列酮通过抑制 EP4 受体表达炎症介质来预防非甾体抗炎药诱导的小肠损伤。
J Pharmacol Exp Ther. 2014 Jun;349(3):470-9. doi: 10.1124/jpet.114.213991. Epub 2014 Apr 8.
10
Dual activation of CFTR and CLCN2 by lubiprostone in murine nasal epithelia.利那洛肽激活小鼠鼻黏膜上皮细胞中的 CFTR 和 CLCN2。
Am J Physiol Lung Cell Mol Physiol. 2013 Mar 1;304(5):L324-31. doi: 10.1152/ajplung.00277.2012. Epub 2013 Jan 11.

引用本文的文献

1
Naringenin attenuates slow-transit constipation by regulating the AMPK/mTOR/ULK1 signalling pathway: and studies.柚皮素通过调节AMPK/mTOR/ULK1信号通路减轻慢传输型便秘: 及 研究。 (你提供的原文中“and”前后内容似乎不完整,可能影响准确理解。)
Front Pharmacol. 2025 Jun 17;16:1550458. doi: 10.3389/fphar.2025.1550458. eCollection 2025.
2
Rab7-dependent regulation of goblet cell protein CLCA1 modulates gastrointestinal homeostasis.Rab7 依赖性调控杯状细胞蛋白 CLCA1 调节胃肠道稳态。
Elife. 2024 Apr 9;12:RP89776. doi: 10.7554/eLife.89776.
3
The ClC-2 Chloride Channel Activator, Lubiprostone, Improves Intestinal Barrier Function in Biopsies from Crohn's Disease but Not Ulcerative Colitis Patients.

本文引用的文献

1
Abating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acid.通过缺失脂磷壁酸的嗜酸乳杆菌来减少结肠息肉。
Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10462-7. doi: 10.1073/pnas.1207230109. Epub 2012 Jun 11.
2
An ex vivo method for studying mucus formation, properties, and thickness in human colonic biopsies and mouse small and large intestinal explants.一种用于研究人类结肠活检和小鼠小肠和大肠外植体中黏液形成、性质和厚度的离体方法。
Am J Physiol Gastrointest Liver Physiol. 2012 Feb 15;302(4):G430-8. doi: 10.1152/ajpgi.00405.2011. Epub 2011 Dec 8.
3
The extraordinarily complex but highly structured organization of intestinal mucus-gel unveiled in multicolor images.
氯离子通道蛋白2(ClC-2)激活剂鲁比前列酮可改善克罗恩病患者活检组织的肠道屏障功能,但对溃疡性结肠炎患者无效。
Pharmaceutics. 2023 Mar 2;15(3):811. doi: 10.3390/pharmaceutics15030811.
4
Intelectin-1 binds and alters the localization of the mucus barrier-modifying bacterium Akkermansia muciniphila.肠凝集素-1 结合并改变黏液屏障修饰菌阿克曼氏菌的定位。
J Exp Med. 2023 Jan 2;220(1). doi: 10.1084/jem.20211938. Epub 2022 Nov 22.
5
The Impact of Gut Microbiota on Post-Stroke Management.肠道微生物群对中风后管理的影响。
Front Cell Infect Microbiol. 2021 Oct 12;11:724376. doi: 10.3389/fcimb.2021.724376. eCollection 2021.
6
Fueling Gut Microbes: A Review of the Interaction between Diet, Exercise, and the Gut Microbiota in Athletes.为肠道微生物供能:饮食、运动与运动员肠道微生物组相互作用的综述。
Adv Nutr. 2021 Dec 1;12(6):2190-2215. doi: 10.1093/advances/nmab077.
7
Recent Progress in the Diagnosis and Precise Nanocarrier-Mediated Therapy of Inflammatory Bowel Disease.炎症性肠病诊断与精确纳米载体介导治疗的最新进展
J Inflamm Res. 2021 Apr 29;14:1701-1716. doi: 10.2147/JIR.S304101. eCollection 2021.
8
Inflammatory Bowel Disease: The Emergence of New Trends in Lifestyle and Nanomedicine as the Modern Tool for Pharmacotherapy.炎症性肠病:生活方式新趋势与纳米医学作为现代药物治疗工具的兴起
Nanomaterials (Basel). 2020 Dec 9;10(12):2460. doi: 10.3390/nano10122460.
9
Proteome and microbiota analysis highlight TWK10 supplementation improves energy metabolism and exercise performance in mice.蛋白质组和微生物群分析表明,补充TWK10可改善小鼠的能量代谢和运动表现。
Food Sci Nutr. 2020 Jun 3;8(7):3525-3534. doi: 10.1002/fsn3.1635. eCollection 2020 Jul.
10
Diarrhea Induced by Small Molecule Tyrosine Kinase Inhibitors Compared With Chemotherapy: Potential Role of the Microbiome.小分子酪氨酸激酶抑制剂引起的腹泻与化疗引起的腹泻比较:微生物组的潜在作用。
Integr Cancer Ther. 2020 Jan-Dec;19:1534735420928493. doi: 10.1177/1534735420928493.
多色图像揭示出肠道黏液凝胶超乎寻常的复杂但高度结构化的组织。
PLoS One. 2011 Apr 12;6(4):e18761. doi: 10.1371/journal.pone.0018761.
4
Lubiprostone activates Cl- secretion via cAMP signaling and increases membrane CFTR in the human colon carcinoma cell line, T84.鲁比前列酮通过 cAMP 信号激活 Cl-分泌,并增加人结肠癌细胞系 T84 中的膜 CFTR。
Dig Dis Sci. 2011 Feb;56(2):339-51. doi: 10.1007/s10620-010-1495-8. Epub 2010 Dec 8.
5
The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions.结肠的两层黏液层由 MUC2 黏蛋白构成,而外层则是调控宿主-微生物相互作用的立法者。
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1(Suppl 1):4659-65. doi: 10.1073/pnas.1006451107. Epub 2010 Jun 25.
6
Evidence of intestinal inflammation in patients with cystic fibrosis.囊性纤维化患者的肠道炎症证据。
J Pediatr Gastroenterol Nutr. 2010 Sep;51(3):304-8. doi: 10.1097/MPG.0b013e3181d1b013.
7
Lubiprostone stimulates duodenal bicarbonate secretion in rats.鲁比前列酮刺激大鼠十二指肠碳酸氢盐分泌。
Dig Dis Sci. 2009 Oct;54(10):2063-9. doi: 10.1007/s10620-009-0907-0. Epub 2009 Aug 6.
8
Immunomodulatory effects of Lactobacillus plantarum on human colon cancer cells.植物乳杆菌对人结肠癌细胞的免疫调节作用。
Int Immunopharmacol. 2009 Oct;9(11):1265-71. doi: 10.1016/j.intimp.2009.07.008. Epub 2009 Jul 29.
9
Activation of intestinal Cl- secretion by lubiprostone requires the cystic fibrosis transmembrane conductance regulator.鲁比前列酮激活肠道氯离子分泌需要囊性纤维化跨膜传导调节因子。
Gastroenterology. 2009 Sep;137(3):976-85. doi: 10.1053/j.gastro.2009.05.037. Epub 2009 May 18.
10
16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis.基于16S rRNA基因的有和无坏死性小肠结肠炎的早产儿粪便微生物群分析。
ISME J. 2009 Aug;3(8):944-54. doi: 10.1038/ismej.2009.37. Epub 2009 Apr 16.